Supportive use of amifostine in patients with head and neck tumors undergoing radio-chemotherapy. Is it possible to limit the duration of the application of amifostine? [electronic resource]
Producer: 19991217Description: 23-6 p. digitalISSN:- 0179-7158
- Adolescent
- Adult
- Aged
- Amifostine -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Carboplatin -- administration & dosage
- Carcinoma, Squamous Cell -- drug therapy
- Combined Modality Therapy
- Head and Neck Neoplasms -- drug therapy
- Humans
- Leukocyte Count
- Middle Aged
- Platelet Count
- Prognosis
- Radiation-Protective Agents -- administration & dosage
- Radiodermatitis -- etiology
- Radionuclide Imaging
- Radiotherapy -- adverse effects
- Radiotherapy Dosage
- Salivary Glands -- diagnostic imaging
- Skin Temperature
- Time Factors
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.